Please login to the form below

Not currently logged in
Email:
Password:

Ariad Pharma

This page shows the latest Ariad Pharma news and features for those working in and with pharma, biotech and healthcare.

Takeda rebels take aim at Shire acquisition

Takeda rebels take aim at Shire acquisition

of bolt-on acquisitions and licensing deals, including the $5.2bn takeover of cancer company Ariad Pharma.

Latest news

  • Angelini to market Ariad’s Iclusig in Eastern Europe Angelini to market Ariad’s Iclusig in Eastern Europe

    Angelini to market Ariad’ s Iclusig in Eastern Europe. Comes after leukaemia drug passes EMA safety review. ... US pharma company Ariad Pharmaceuticals has licensed its cancer drug Iclusig to Italy-based firm Angelini Pharma to market in 23 Eastern

  • Pfizer faces NICE rejection for cancer drug Bosulif Pfizer faces NICE rejection for cancer drug Bosulif

    In April 2013 an article in the journal Blood saw 20 physicians specialising in CML treatment call for price reductions for CML drugs, claiming that Bosulif, Ariad Pharma's Iclusig (ponatinib) ... So far this pressure has been focused on the US, however

  • Leukaemia drug prices Leukaemia drug prices "unsustainable" say cancer experts

    The experts single out three new drugs for CML approved by the FDA last year - Pfizer's Bosulif (bosutinib), Ariad Pharma's Iclusig (ponatinib) and Teva's Synribo (omacetaxine) - which they

  • EU recommendations for Gilead, Ariad and Baxter drugs EU recommendations for Gilead, Ariad and Baxter drugs

    Gilead Sciences, Ariad Pharma and Baxter have all received backing from the European Medicines Agency (EMA) to market new treatments. ... Iclusig approved to treat leukaemia. The CHMP also gave a positive opinion to Ariad Pharma for the use of Iclusig

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Ali Frederic Ben-Amor
Tackling a formidable foe
Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...
Geoff
Cancer care – the power of new technologies
With patient numbers set to soar, how can we make a difference?...
image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...

Infographics